Published in Schizophr Res on January 08, 2008
Functional consequences of marijuana use in adolescents. Pharmacol Biochem Behav (2009) 1.71
Altered white matter microstructure in adolescent substance users. Psychiatry Res (2009) 1.58
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol (2010) 1.33
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol (2011) 1.02
Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) (2009) 1.01
The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull (2010) 1.00
Focal and global brain measurements in siblings of patients with schizophrenia. Schizophr Bull (2011) 0.92
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol (2008) 0.88
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci (2012) 0.88
The role of untreated psychosis in neurodegeneration: a review of hypothesized mechanisms of neurotoxicity in first-episode psychosis. Can J Psychiatry (2014) 0.86
Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des (2012) 0.84
An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia. Front Psychiatry (2014) 0.84
Endocannabinoid system: potential novel targets for treatment of schizophrenia. Neurobiol Dis (2012) 0.82
Peripheral endocannabinoid system dysregulation in first-episode psychosis. Neuropsychopharmacology (2013) 0.81
Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review. J Addict Dis (2009) 0.80
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry (2015) 0.80
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial. Trials (2016) 0.78
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. J Psychiatry Neurosci (2015) 0.77
MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse. Psychol Med (2012) 0.77
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use. Front Psychiatry (2012) 0.77
The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. Front Psychiatry (2014) 0.77
The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study. Schizophr Res Treatment (2013) 0.76
Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology (Berl) (2015) 0.76
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use. Schizophr Bull (2016) 0.75
Lifetime use of cannabis from longitudinal assessments, cannabinoid receptor (CNR1) variation, and reduced volume of the right anterior cingulate. Psychiatry Res (2016) 0.75
Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder. J Neuropsychiatry Clin Neurosci (2016) 0.75
Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis. Psychiatry Res (2016) 0.75
Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis. Transl Psychiatry (2017) 0.75
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol (2017) 0.75
Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res (2008) 5.99
Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr Res (2009) 3.68
Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. Biol Psychiatry (2002) 2.74
Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophr Res (2010) 2.47
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders. Alcohol Clin Exp Res (2005) 2.16
Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull (2003) 2.04
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry (2013) 1.85
Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry (2010) 1.80
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.76
An MRI study of increased cortical thickness in autism. Am J Psychiatry (2006) 1.72
Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophr Res (2008) 1.71
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv (2009) 1.62
Increased frontal cortical folding in autism: a preliminary MRI study. Psychiatry Res (2004) 1.58
Assessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test. Schizophr Bull (2008) 1.56
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54
Development of the corpus callosum in childhood, adolescence and early adulthood. Life Sci (2002) 1.47
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry (2006) 1.43
Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett (2002) 1.39
Cross-sectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry (2004) 1.38
Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull (2009) 1.36
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull (2003) 1.34
A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus. Schizophr Bull (2003) 1.34
Smaller cingulate volumes in unipolar depressed patients. Biol Psychiatry (2006) 1.33
A preliminary longitudinal magnetic resonance imaging study of brain volume and cortical thickness in autism. Biol Psychiatry (2009) 1.33
Psychopathology among offspring of parents with schizophrenia: relationship to premorbid impairments. Schizophr Res (2008) 1.32
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia. Schizophr Res (2004) 1.30
Sex differences in brain maturation in maltreatment-related pediatric posttraumatic stress disorder. Neurosci Biobehav Rev (2003) 1.28
Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry (2004) 1.26
Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res (2004) 1.26
Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr Res (2002) 1.23
Anatomical MRI study of borderline personality disorder patients. Psychiatry Res (2004) 1.23
Cingulate cortex anatomical abnormalities in children and adolescents with bipolar disorder. Am J Psychiatry (2005) 1.23
Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr Res (2003) 1.23
Disruption of orbitofrontal cortex laterality in offspring from multiplex alcohol dependence families. Biol Psychiatry (2008) 1.21
An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res (2008) 1.20
Anatomic evaluation of the orbitofrontal cortex in major depressive disorder. Biol Psychiatry (2004) 1.20
Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophr Bull (2004) 1.19
Motor performance and anatomic magnetic resonance imaging (MRI) of the basal ganglia in autism. J Child Neurol (2003) 1.19
Insight and frontal cortical function in schizophrenia: a review. Schizophr Res (2006) 1.18
"Just the facts": meandering in schizophrenia's many forests. Schizophr Res (2011) 1.18
Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial. Schizophr Bull (2012) 1.17
Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage (2003) 1.17
Cognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects. Schizophr Res (2006) 1.16
Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Am J Psychiatry (2004) 1.16
Corpus callosum volume in children with autism. Psychiatry Res (2009) 1.16
Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. Biol Psychiatry (2002) 1.14
Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res (2005) 1.14
Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia. Psychol Med (2006) 1.13
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12
Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry (2003) 1.10
Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09
Brain structure and symptom dimension relationships in obsessive-compulsive disorder: a voxel-based morphometry study. J Affect Disord (2008) 1.09
Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.08
Cognitive training in mental disorders: update and future directions. Am J Psychiatry (2014) 1.07
Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study. Psychiatry Res (2005) 1.06
Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.06
Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia. Biol Psychiatry (2005) 1.05
Corpus callosum volume and neurocognition in autism. J Autism Dev Disord (2009) 1.04
Volumetric alterations of the orbitofrontal cortex in autism. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.04
Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage (2004) 1.03
Dorsolateral prefrontal cortex morphology and short-term outcome in first-episode schizophrenia. Psychiatry Res (2005) 1.03
Magnetic resonance imaging study of corpus callosum abnormalities in patients with bipolar disorder. Biol Psychiatry (2003) 1.02
Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophr Res (2010) 1.02
The entorhinal cortex in first-episode psychotic disorders: a structural magnetic resonance imaging study. Am J Psychiatry (2004) 1.02
Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder. Biol Psychiatry (2012) 1.02
Reduced cortical folding in individuals at high risk for schizophrenia: a pilot study. Schizophr Res (2004) 1.02
Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry (2002) 1.02
Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci (2010) 1.01
Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol Psychiatry (2007) 1.01
Anatomical MRI study of subgenual prefrontal cortex in bipolar and unipolar subjects. Neuropsychopharmacology (2002) 1.01
Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res (2003) 1.01
Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study. World Psychiatry (2004) 1.01
Multivariate prediction of emerging psychosis in adolescents at high risk for schizophrenia. Schizophr Res (2012) 1.01
One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophr Res (2010) 1.00
1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology (2004) 0.99
A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.99
Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia. Biol Psychiatry (2008) 0.99
Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res (2012) 0.99
Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. Psychiatry Res (2005) 0.99
Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome. Neuroimage (2004) 0.99
Magnetic resonance imaging study of the orbitofrontal cortex in autism. J Child Neurol (2006) 0.98
Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression. Psychiatry Res (2009) 0.98
Abnormal brain size effect on the thalamus in autism. Psychiatry Res (2006) 0.98
1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord (2005) 0.98